Literature DB >> 11439042

Intermediate in beta-lactam hydrolysis catalyzed by a dinuclear zinc(II) complex: relevance to the mechanism of metallo-beta-lactamase.

N V Kaminskaia1, B Spingler, S J Lippard.   

Abstract

Inactivation of beta-lactam antibiotics by metallo-beta-lactamase enzymes is a well-recognized pathway of antibiotic resistance in bacteria. As part of extensive mechanistic studies, the hydrolysis of a beta-lactam substrate nitrocefin (1) catalyzed by dinuclear zinc(II) model complexes was investigated in nonaqueous solutions. The initial step involves monodentate coordination of the nitrocefin carboxylate group to the dizinc center. The coordinated substrate is then attacked intramolecularly by the bridging hydroxide to give a novel intermediate (2') characterized by its prominent absorbance maximum at 640 nm, which affords a blue color. The NMR and IR spectroscopic data of 2' are consistent with it being zinc(II)-bound N-deprotonated hydrolyzed nitrocefin that forms from the tetrahedral intermediate upon C-N bond cleavage. Protonation of the leaving group is the rate-limiting step in DMSO solution and occurs after the C-N bond-breaking step. Addition of strong acids results in rapid conversion of 2' into hydrolyzed nitrocefin (3). The latter can be converted back to the blue species (2') upon addition of base. The low pK(a) value for the amino group in hydrolyzed nitrocefin is explained by its involvement in extended conjugation and by coordination to zinc(II). The blue intermediate (2') in the model system resembles well that in the enzymatic system, judging by its optical properties. The greater stability of the intermediate in the model, however, allowed its characterization by (13)C NMR and infrared, as well as electronic, spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439042     DOI: 10.1021/ja002699e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

1.  Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.

Authors:  Hanna-Kirsti S Leiros; Pardha S Borra; Bjørn Olav Brandsdal; Kine Susann Waade Edvardsen; James Spencer; Timothy R Walsh; Orjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Zinc and antibiotic resistance: metallo-beta-lactamases and their synthetic analogues.

Authors:  A Tamilselvi; Govindasamy Mugesh
Journal:  J Biol Inorg Chem       Date:  2008-07-22       Impact factor: 3.358

Review 3.  Overcoming differences: The catalytic mechanism of metallo-β-lactamases.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

4.  A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1.

Authors:  Kongkai Zhu; Junyan Lu; Zhongjie Liang; Xiangqian Kong; Fei Ye; Lu Jin; Heji Geng; Yong Chen; Mingyue Zheng; Hualiang Jiang; Jun-Qian Li; Cheng Luo
Journal:  J Comput Aided Mol Des       Date:  2013-03-02       Impact factor: 3.686

5.  Molecular design of an acid-base cooperative catalyst for RNA cleavage based on a dizinc complex.

Authors:  Morio Yashiro; Ryuto Kawahara
Journal:  J Biol Inorg Chem       Date:  2004-09-15       Impact factor: 3.358

6.  Motion of the zinc ions in catalysis by a dizinc metallo-beta-lactamase.

Authors:  Robert M Breece; Zhenxin Hu; Brian Bennett; Michael W Crowder; David L Tierney
Journal:  J Am Chem Soc       Date:  2009-08-26       Impact factor: 15.419

7.  Role of the Zn1 and Zn2 sites in metallo-beta-lactamase L1.

Authors:  Zhenxin Hu; Gopalraj Periyannan; Brian Bennett; Michael W Crowder
Journal:  J Am Chem Soc       Date:  2008-10-03       Impact factor: 15.419

Review 8.  Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Authors:  Antonella R Palacios; María-Agustina Rossi; Graciela S Mahler; Alejandro J Vila
Journal:  Biomolecules       Date:  2020-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.